MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Methocarbamol

Methocarbamol 750mg tablets

Use with caution

Stability notes for Methocarbamol 750mg tablets

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Robaxin 750 tablets (Almirall Ltd).

Suppliers (11) of Methocarbamol 750mg tablets
Methocarbamol 750mg tablets (A A H Pharmaceuticals Ltd)
Methocarbamol 750mg tablets (Alliance Healthcare (Distribution) Ltd)
Methocarbamol 750mg tablets (Amarox Ltd)
Methocarbamol 750mg tablets (Aristo Pharma Ltd)
Methocarbamol 750mg tablets (Genesis Pharmaceuticals Ltd)
Methocarbamol 750mg tablets (Medihealth (Northern) Ltd)
Methocarbamol 750mg tablets (Milpharm Ltd)
Methocarbamol 750mg tablets (Neuraxpharm UK Ltd)
Methocarbamol 750mg tablets (Sigma Pharmaceuticals Plc)
Methocarbamol 750mg tablets (Somex Pharma)
Robaxin 750 tablets (Almirall Ltd)

Methocarbamol 1500mg tablets

No stability information

Stability notes for Methocarbamol 1500mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Methocarbamol 1500mg tablets
Methocarbamol 1500mg tablets (Alliance Healthcare (Distribution) Ltd)
Methocarbamol 1500mg tablets (Amarox Ltd)
Methocarbamol 1500mg tablets (Consilient Health Ltd)
Methocarbamol 1500mg tablets (Neuraxpharm UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.